Pharma Pass II LLC
Records under this name other than patents Pharma Pass II LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Pharma Pass II LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,139,815 | Stem cells derived from bone marrow for tissue regeneration Lapsed on the fee record Ended Sep 22, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | USPTO record |
| US 8,968,776 | Composition comprising a benzimidazole and process for its manufacture Formerly held Lapsed on the fee record Ended Mar 3, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 3, 2019 | USPTO record |
| US 6,159,499 | Composition containing an acid-labile benzimidazole and process for its preparation Formerly held Term ended Term ended Oct 20, 2018 · USPTO record | Term ended | Term ended Oct 20, 2018 | USPTO record |
| US 6,350,471 | Tablet comprising a delayed release coating Formerly held Lapsed on the fee record Ended Feb 26, 2006 · USPTO record | Lapsed on the fee record | Ended Feb 26, 2006 | USPTO record |